Retatrutide RT50 50mg*10vials

Retatrutide RT50 50mg x 10 Vials

Product Overview

Retatrutide RT50 is the flagship product in the entire Retatrutide triad receptor agonist series, representing the highest-specification and most potent GLP-1 and GIP and GCGR metabolic research peptide. RT50 is developed based on all previous RT series iterations including RT10, RT15, RT20, RT30, and RT40, employing full-spectrum saturated molecular optimization and maximum-density active ingredient configuration to support unparalleled target binding efficiency, extremely strong metabolic regulatory intensity, and industry-leading experimental stability research. As the highest-dose and most potent research-grade retatrutide currently available, it is specifically tailored for ultra-limited metabolic mechanism research, ultra-high-dose gradient efficacy validation, large-scale long-term preclinical projects, and high-standard extreme phenotypic modeling, serving as a top-tier core raw material for professional pharmaceutical laboratories and advanced metabolic research institutions.

Core Research Functions

Full-Saturation Effect of Synergistic Metabolic Regulation Across Three Pathways: Supports full-saturation effect of synergistic metabolic regulation across three pathways research, providing comprehensive in-depth extreme intervention in complex systemic metabolic disorders.

Fully Activated GLP-1 and GIP Dual Pathways and Insulin Sensitivity Ultimate Optimization: Supports fully activated GLP-1 and GIP dual pathways research, insulin sensitivity ultimate optimization studies, refractory severe insulin resistance related improvement research, long-term stable glycemic homeostasis maintenance research, and super-strong long-lasting appetite suppression and satiety production research, providing excellent reliable experimental support for in-depth exploration of advanced diabetes pathogenesis and complex glucose metabolism disorders.

Fully Enhanced GCGR Pathway and Resting Energy Expenditure Maximization: Supports fully enhanced GCGR pathway research, resting energy expenditure maximization studies, deep visceral fat and refractory adipose tissue deep oxidative decomposition achievement research, refractory severe dyslipidemia significant improvement research, and white adipose tissue complete browning remodeling promotion research.

Most Challenging Advanced Research Directions and Highly Significant Experimental Phenotypes: Supports most challenging advanced research directions including refractory extreme obesity, multidimensional metabolic remodeling throughout the entire life cycle, deep repair of metabolic organ damage, and ultra-high dose-effect boundary validation research. It supports highly significant experimental phenotypes generation research, ultra-high precision data provision studies, and excellent reproducibility research, providing comprehensive support for high-end preclinical research and top academic results production.

Retatrutide RT50 supports full-saturation effect of synergistic metabolic regulation across three pathways research, providing comprehensive in-depth extreme intervention in complex systemic metabolic disorders. Its fully activated GLP-1 and GIP dual pathways support insulin sensitivity ultimate optimization research, refractory severe insulin resistance related improvement research, long-term stable glycemic homeostasis maintenance research, and super-strong long-lasting appetite suppression and satiety production research. The fully enhanced GCGR pathway supports resting energy expenditure maximization studies, deep visceral fat and refractory adipose tissue deep oxidative decomposition achievement research, refractory severe dyslipidemia significant improvement research, and white adipose tissue complete browning remodeling promotion research. RT50 supports highly significant experimental phenotypes generation research, ultra-high precision data provision studies, and excellent reproducibility research, providing comprehensive support for high-end preclinical research and top academic results production.

Core Product Advantages

RT50 Fully Saturated Ultimate Potency: The final iteration of the Retatrutide series, with a saturated optimized molecular structure, supporting target binding activity maximization research. Its overall metabolic regulatory efficacy supports all lower-generation RT products complete surpass research, providing significant experimental differential phenotypes for high-standard scientific research.

50mg Full-Strength High Concentration: The top-of-the-line commercial flagship specification in the Retatrutide product line, with concentrations 5 times that of the traditional 10mg, 2.5 times that of 20mg, 1.67 times that of 30mg, and 1.25 times that of 40mg. Suitable for ultra-long-term large animal models, extremely high-dose gradient control experiments, and large-scale multi-group parallel replicate experiments, supporting frequent dilution and solution changes caused data deviations related avoidance research.

Top-Tier Resistance to Degradation and Overall Stability: Utilizing the latest fully stable molecular modification technology, it supports strong resistance to in vitro and in vivo metabolic decay research. Maintaining saturated biological activity throughout the entire long experimental period with minimal attenuation research, providing stable highly consistent and reproducible experimental data research.

Pharmaceutical-Grade Ultra-High Purity: Employing a sterile vacuum freeze-drying process to support peptide molecules activity full retention research. Each batch of products undergoes rigorous HPLC purity testing and is accompanied by a complete Certificate of Analysis COA, supporting ultra-low impurity content, low contamination risk, and top-tier pharmaceutical research-grade quality research.

Standardized High-End Bulk Packaging: 10 vials per box, integrated aseptic packaging, suitable for long-term strategic reserves in laboratories, top-tier preclinical research by pharmaceutical companies, key national research projects, and large-scale global wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 50mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis COA.